SEARCH WITHIN CONTENT
Citation Information : Immunohematology. Volume 34, Issue 2, Pages 39-45, DOI: https://doi.org/10.21307/immunohematology-2018-007
License : (Transfer of Copyright)
Published Online: 16-October-2019
This article reviews information regarding the clinical significance of antibodies to antigens in the blood group collections, the 700 series of low-incidence antigens, and the 901 series of high-incidence antigens. Antibodies to many of the antigens in these groups are rarely encountered, meaning that available information is limited. For a few, the clinical significance— the potential to cause reduced survival of transfused antigen-positive red blood cells, a hemolytic transfusion reaction (e.g., anti-AnWj, anti-Emm), or hemolytic disease of the fetus and newborn (e.g., anti-Kg, anti-HJK)—has been documented. Many other specificities have so far been benign (e.g., anti-Csa, anti-M1).